Development of Reference Control Material for the Evaluation of the Cepheid Prototype * Xpert® BCR-ABL P190 Ultra Assay

被引：0
|
作者：
Liu, Yuanyuan [1 ]
Tran Tran [1 ]
Phat Nguyen [1 ]
Wei, Huilin [1 ]
Day, Gwo-Jen [1 ]
Yuan, Lin [1 ]
机构：
[1] Cepheid, Oncol, R&D, Sunnyvale, CA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128856
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] COMPARATIVE EVALUATION BETWEEN THE GENEXPERT/XPERT BCR-ABL ULTRA METHOD AND THE MANUAL TEST OF A REFERENCE LABORATORY FOR THE QUANTIFICATION OF THE BCR-ABL1 GENE (P210)
    Dolors, Colomer
    Sandra, Cabezas
    Sandra, Martinez
    Monica, Lopez-Guerra
    Jeff, Robson
    HAEMATOLOGICA, 2016, 101 : 243 - 243
  • [22] Strategies for validation of a low-volume BCR::ABL p190 assay in the clinical laboratory
    Hernandez, Patricia
    Kowalewski, Rodney
    Stroup, Brooke
    Hrabusicky, Lori
    Parikh, Bijal
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S120 - S120
  • [23] Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
    Scrideli, Carlos Alberto
    de Oliveira, Fabio Morato
    Brassesco, Maria Sol
    Queiroz, Rosane de Paula
    Bernardes, Jose Eduardo
    Valera, Elvis Terci
    Tone, Luiz Gonzaga
    LEUKEMIA RESEARCH, 2009, 33 (03) : 495 - 499
  • [24] Strategies for validation of a low-volume BCR::ABL p190 assay in the clinical laboratory
    Hernandez, Patricia
    Kowalewski, Rodney
    Stroup, Brooke
    Hrabusicky, Lori
    Parikh, Bijal
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S120 - S120
  • [25] Chronic Myeloid Leukemia With P190 BCR-ABL Translocation and Persistent Moderate Monocytosis: A Case Report
    Gatti, Arianna
    Movilia, Alessandra
    Roncoroni, Lucia
    Citro, Annalisa
    Marinoni, Sara
    Brando, Bruno
    JOURNAL OF HEMATOLOGY, 2018, 7 (03) : 120 - 123
  • [26] Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangement
    Veelken, H
    Licht, T
    Lais, A
    Köhler, G
    Mertelsmann, R
    Schaefer, HE
    Lübbert, M
    LEUKEMIA RESEARCH, 1998, 22 (11) : 1021 - 1027
  • [27] All common p210 and p190 Bcr-abl variants can be targeted by RNA interference
    Wohlbold, L
    van der Kuip, H
    Moehring, A
    Granot, G
    Oren, M
    Vornlocher, HP
    Aulitzky, WE
    LEUKEMIA, 2005, 19 (02) : 290 - 292
  • [28] All common p210 and p190 Bcr-abl variants can be targeted by RNA interference
    L Wohlbold
    H van der Kuip
    A Moehring
    G Granot
    M Oren
    H-P Vornlocher
    W E Aulitzky
    Leukemia, 2005, 19 : 290 - 292
  • [29] Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation
    Score, J.
    Calasanz, M. J.
    Ottman, O.
    Pane, F.
    Yeh, R. F.
    Sobrinho-Simoes, M. A.
    Kreil, S.
    Ward, D.
    Hidalgo-Curtis, C.
    Melo, J. V.
    Wiemels, J.
    Nadel, B.
    Cross, N. C. P.
    Grand, F. H.
    LEUKEMIA, 2010, 24 (10) : 1742 - 1750
  • [30] Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia
    Lichty, BD
    Keating, A
    Callum, J
    Yee, K
    Croxford, R
    Corpus, G
    Nwachukwu, B
    Kim, P
    Guo, J
    Kamel-Reid, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (03) : 711 - 715
12345